A

Aker Biomarine ASA
OSE:AKBM

Watchlist Manager
Aker Biomarine ASA
OSE:AKBM
Watchlist
Price: 105 NOK 0.96%
Market Cap: kr9.2B

EV/EBITDA

20.5
Current
94%
More Expensive
vs 3-y average of 10.6

Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.

EV/EBITDA
20.5
=
Enterprise Value
kr10.7B
/
EBITDA
$53.5m

Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.

EV/EBITDA
20.5
=
Enterprise Value
kr10.7B
/
EBITDA
$53.5m

Valuation Scenarios

Aker Biomarine ASA is trading above its 3-year average

If EV/EBITDA returns to its 3-Year Average (10.6), the stock would be worth kr54.07 (49% downside from current price).

Statistics
Positive Scenarios
0/4
Maximum Downside
-62%
Maximum Upside
No Upside Scenarios
Average Downside
54%
Scenario EV/EBITDA Value Implied Price Upside/Downside
Current Multiple 20.5 kr105
0%
3-Year Average 10.6 kr54.07
-49%
5-Year Average 10.8 kr55.41
-47%
Industry Average 8.8 kr45.07
-57%
Country Average 7.8 kr39.79
-62%

Forward EV/EBITDA
Today’s price vs future ebitda

Today's Enterprise Value EBITDA Forward EV/EBITDA
kr10.7B
/
Jan 2026
$53.5m
=
20.5
Current
kr10.7B
/
Dec 2026
$65.1m
=
164.9
Forward
kr10.7B
/
Dec 2027
$82.5m
=
130.1
Forward
kr10.7B
/
Dec 2028
$95.4m
=
112.6
Forward

Forward EV/EBITDA shows whether today’s EV/EBITDA still looks high or low once future ebitda are taken into account.

Peer Comparison

All Multiples
EV/EBITDA
P/E
All Countries
Close
Market Cap EV/EBITDA P/E
NO
Aker Biomarine ASA
OSE:AKBM
9.2B NOK 20.5 -42
JP
Goyo Foods Industry Co Ltd
TSE:2230
53.2T JPY 186 542.5 540 752.8
CH
Nestle SA
SIX:NESN
197.5B CHF 13.3 21.5
US
Mondelez International Inc
NASDAQ:MDLZ
73.4B USD 18 29.6
FR
Danone SA
PAR:BN
43.5B EUR 9.6 23.5
ZA
Tiger Brands Ltd
JSE:TBS
49.9B ZAR 9.7 13.1
US
Hershey Co
NYSE:HSY
38.8B USD 21.2 43.6
CN
Muyuan Foods Co Ltd
SZSE:002714
247.6B CNY 15.9 16
CN
Foshan Haitian Flavouring and Food Co Ltd
SSE:603288
235.3B CNY 25.2 33.4
ZA
Avi Ltd
JSE:AVI
33.7B ZAR 8.9 13
CH
Chocoladefabriken Lindt & Spruengli AG
SIX:LISN
24.4B CHF 19.3 32.5

Market Distribution

Higher than 74% of companies in Norway
Percentile
74th
Based on 539 companies
74th percentile
20.5
Low
0.1 — 2.2
Typical Range
2.2 — 16.6
High
16.6 —
Distribution Statistics
Norway
Min 0.1
30th Percentile 2.2
Median 7.8
70th Percentile 16.6
Max 40 612.5

Aker Biomarine ASA
Glance View

Market Cap
9.2B NOK
Industry
Food Products

Aker BioMarine AS operates as a biotech innovator and Antarctic krill-harvesting company which develops krill-based ingredients for nutraceutical, aquaculture, and animal feed applications. The company is headquartered in Lysaker, Akershus. The company went IPO on 2020-07-06. The company consists of two business segments: Ingredients and Brands. Under The Ingredients segment, the Company develops krillbased ingredients for human applications in the nutraceutical and dietary supplement space, and animal feed applications for aquaculture and pet food. Under The Brands segment, the Company has two companies: Lang Pharma Nutrition and Epion Brands. Lang Pharma Nutrition is a full service, mass market private label and corporate brand manufacturer within supplements. Epion Brands has its own consumer brand in the US market, Kori, being on the shelves of retailers. Aker BioMarine’s focus on sustainability inspired the launch of AION by Aker BioMarine, a circularity company dedicated to helping companies to recycle and reuse waste.

AKBM Intrinsic Value
60.29 NOK
Overvaluation 43%
Intrinsic Value
Price kr105
A
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett